Loan & DebtSep 16, 2026, 05:12 PM
Ekso Bionics Holdings Extends Loan Maturity to Nov 2026
AI Summary
Ekso Bionics Holdings, Inc. (now ChronoScale Intermediate, LLC) has entered into a First Amendment to its Secured Promissory Note and Security Agreement with B. Riley Commercial Capital, LLC. The amendment extends the maturity date of the $2.0 million term loan from its original 12-month anniversary to November 12, 2026. Crucially, the amendment also defines the sale of the Guarantor, Ekso Bionics, Inc., as a 'Permitted Disposition,' which will allow for the automatic release of liens on the sold assets without further action from the lender. All other terms of the original agreement remain unchanged.
Key Highlights
- ChronoScale Intermediate, LLC (f/k/a Ekso Bionics Holdings, Inc.) amended its Secured Promissory Note and Security Agreement with B. Riley Commercial Capital, LLC.
- The maturity date for the $2.0 million term loan has been extended from its original 12-month anniversary to November 12, 2026.
- The amendment allows for the sale of the Guarantor (Ekso Bionics, Inc.) as a Permitted Disposition without triggering a default.
- Security interests and liens will be automatically released upon the consummation of a Permitted Disposition.
- The principal amount outstanding under the Term Loan remains $2.0 million as of the amendment date.
Price Impact
More from EKSO